Pharma Journalist -

Amgen and Simcere Pharmaceutical Group announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China. The collaboration includes…
Read More...

Teva Pharmaceutical Industries announced the reintroduction of the generic equivalent to Depo-Provera1 Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP)…
Read More...

Gilead Sciences  announced that the China Food and Drug Administration(CFDA) has approved Sovaldi (sofosbuvir 400mg), a once-daily oral nucleotide analog polymerase inhibitor for the…
Read More...

In an effort to improve health outcomes of people with type 2 diabetes, Geisinger and Boehringer Ingelheim, on behalf of its diabetes alliance with Eli Lilly and Company announced a…
Read More...

Catalent announced it has reached an agreement to acquire Bloomington, Indiana-based Cook Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and…
Read More...

Lung cancer patients in England can now be prescribed nivolumab, also known as Opdivo, after NICE says it should be available through the Cancer Drugs Fund (CDF). Around 1,300 lung…
Read More...

NICE is urging GPs to manage most common ear infections with pain relief rather than antibiotics. The draft guidance advises GPs and healthcare professionals how they should treat…
Read More...

Recipharm AB announces today that it has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose…
Read More...

To ensure patients and providers have access to important, lower cost biosimilar medicines, Pfizer filed suit in the U.S. District Court for the Eastern District of Pennsylvania against…
Read More...

Novartis announced that the European Commission (EC) approved Rydapt® (midostaurin) for two indications in rare, hard-to-treat cancers. Rydapt is approved for use in combination with…
Read More...